FeesSafety
Pluang+

Midera Food Processing to release Q3 2026 earnings on Nov 17 with a conference call.

Company Fundamentals
29 Oct 2026, 15:00 WIB
GlobeNewsWire
View Source
Neutral
Midera Food Processing to release Q3 2026 earnings on Nov 17 with a conference call.

Midera Food Processing, a global provider of food processing equipment, will announce its fiscal third quarter 2026 earnings on November 17, 2026, before the market opens. The company will hold a conference call at 9:00 AM CT to discuss the results, accessible via a live webcast on its investor relations website. This follows Midera's recent activities including acquisitions and strong growth after becoming an independent public company. Investors can expect insights into the company's performance and strategic direction during the call.

Midera Food Processing's upcoming Q3 2026 earnings announcement is noted here for context. For readers following Industrials-sector stocks, 76 of 135 priced US stocks rose while 57 fell on Pluang. Notable movers as of Oct 29, 2026 17:53 WIB include CAT at USD 649.18 with a 9.00% decline, HWM at USD 210.48 up 7.76%, and FTAI at USD 180.00 up 7.69%.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App